1. Home
  2. GHC vs FOLD Comparison

GHC vs FOLD Comparison

Compare GHC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Holdings Company

GHC

Graham Holdings Company

HOLD

Current Price

$1,069.20

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.38

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHC
FOLD
Founded
1877
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
GHC
FOLD
Price
$1,069.20
$14.38
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$27.25
AVG Volume (30 Days)
14.1K
3.0M
Earning Date
04-29-2026
04-30-2026
Dividend Yield
0.70%
N/A
EPS Growth
N/A
50.00
EPS
66.47
N/A
Revenue
$2,932,099,000.00
N/A
Revenue This Year
$10.54
$20.50
Revenue Next Year
$4.02
$18.59
P/E Ratio
$15.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$875.60
$5.66
52 Week High
$1,224.76
$14.39

Technical Indicators

Market Signals
Indicator
GHC
FOLD
Relative Strength Index (RSI) 45.24 68.21
Support Level $1,019.78 $14.21
Resistance Level $1,115.27 N/A
Average True Range (ATR) 30.00 0.02
MACD 3.15 -0.02
Stochastic Oscillator 63.46 71.43

Price Performance

Historical Comparison
GHC
FOLD

About GHC Graham Holdings Company

Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: